ABSTRACT Aim: To characterise the relationship between bronchopulmonary dysplasia (BPD) severity and cognition in the post-surfactant era.
INTRODUCTION
Bronchopulmonary dysplasia (BPD) continues to be a major complication for infants born prematurely. Improved survival at younger gestational ages (22-31 weeks of gestation) in conjunction with therapies such as surfactant and gentler approaches to ventilation have resulted in different manifestations of BPD than originally described by Northway et al. (1) . Modern BPD shows a lack of lung development rather than the scarred, injured lung seen in classic BPD. It encompasses a new lung disease of varying severity ranging from normal alveolarization to severe disease marked by vascular remodelling, interstitial oedema and fibrosis (2) .
With advances in neonatal ventilation, more preterm infants have survived to discharge and the focus has shifted from mortality to morbidities associated with prematurity.
Classically, BPD has been considered a risk factor for poor neurodevelopmental outcomes. In very low birthweight (VLBW) children born 1982-1986, history of BPD predicted neurodevelopmental outcomes at school age (3) . In another cohort born in the United States, children with history of BPD had lower intelligence quotient (IQ) and were more likely to receive special education services at eight years than VLBW children without BPD (4) . Similar results were demonstrated in an Australian cohort of children with history of BPD (5) . More recently, in a cohort of very preterm children in the Netherlands, BPD was a significant risk factor for variance in neurocognitive functions at five years after accounting for sociodemographic and characteristics at birth (6) .
Over the last 30 years, the definition of BPD has evolved along with the patient population (3) (4) (5) (6) . Frequently, BPD is 
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In recent decades, surfactant and gentler ventilation have improved survival of preterm infants. Bronchopulmonary dysplasia (BPD) remains a major morbidity of prematurity. Modern day BPD may not have the same neurodevelopmental ramifications as BPD in the presurfactant era.
diagnosed clinically by the use of supplemental oxygen at 36 weeks postmenstrual age as described by Shennan et al. (7) . Modern BPD is characterised by fewer alveoli and less developed pulmonary microvasculature as a result of gentler ventilation, antenatal corticosteroid use and surfactant therapy in infants of a younger gestational age and lower birthweight (8) . Recently, Walsh and colleagues introduced the physiologic definition of BPD (9) . This resulted in a reduction of BPD rates from 35 to 25% and less variability in the incidence of BPD among centres within the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network (NRN) (10) . Concurrently, Ehrenkranz et al. (11) validated the 2000 NIH Workshop consensus definition for levels of BPD severity which incorporated a severity spectrum from mild to severe. They found that as the severity of BPD worsened, so did the incidence of poor neurodevelopmental outcomes. Similarly, Short et al. (12) found an association between BPD severity and cognition, motor skills and language at three years as well as cognition and special education services at eight years in an older cohort of children born 1989-1991.
Bronchopulmonary dysplasia is a common outcome measure in neonatology yet the simple clinical definition of BPD, the use of supplemental oxygen at 36 weeks postmenstrual age (7), may not accurately distinguish among infants affected by different degrees of pulmonary disease. This definition does not account for variability in clinician and centre practice in the use of supplemental oxygen as well as alternative indications for oxygen use such as retinopathy of prematurity (ROP) (13) . Applying historical data regarding the relationship between BPD and neurodevelopment may overstate the impact of BPD on developmental outcomes for mild-to-moderate BPD today.
The aim of this study was to evaluate the relationship between BPD severity as defined by the NIH Workshop and cognitive outcomes among VLBW infants. We hypothesised that mild and moderate forms of BPD would not show an association with adverse neurodevelopmental outcomes at 18-22 months of corrected age, while severe BPD would continue to be associated with worse cognition in the postsurfactant era.
METHODS
We conducted a single-centre retrospective analysis of a cohort of infants cared for at the University of Iowa Hospitals and Clinics in 2009-2012. Inclusion criteria were as follows: admission within 48 hours of birth, gestational age between 22-0/7 and 31-6/7 weeks' gestation, birthweight between 400 and 1500 g and Bayley Scales of Infant and Toddler Development-III testing in toddlerhood. We excluded outborn infants who were admitted after 48 hours of life, infants with major congenital anomalies and infants for whom resuscitation was not attempted at birth. A total of 166 infants met the inclusion and exclusion criteria. All data were abstracted from maternal and infant medical records. The University of Iowa Institutional Review Board approved the study with a waiver of consent.
Maternal data collected included antenatal steroid exposure, the presence of chorioamnionitis and mode of delivery. Gestational age was calculated from the estimated date of delivery as determined by either last menstrual period or ultrasound (at the obstetrician's discretion). Neonatal data collected included gestational age at birth, demographic information, respiratory support at 28 days, respiratory support at 36 weeks, respiratory distress syndrome (RDS), early onset sepsis (EOS), late onset sepsis (LOS), necrotising enterocolitis (NEC), patent ductus arteriosus (PDA), intraventricular haemorrhage (IVH), periventricular leukomalacia (PVL), seizures, ROP requiring laser photocoagulation and major surgery. BPD was defined as outlined in Table 1 .
The primary outcome was Bayley Scales of Infant and Toddler Development-III (BSID-III) composite cognitive score on a continuous scale administered at 18-26 months of corrected age (14) . The Bayley assesses three key developmental domains through direct observation of the infant: cognition, language (receptive and expressive) and motor (gross and fine). The composite score for each domain has a mean of 100 and standard deviation of 15. Secondary outcomes included Bayley cognitive score <70, Bayley cognitive score <85, Bayley composite language score and Bayley composite motor score. Infants eligible for the Bayley evaluation included infants participating in studies sponsored by the NRN, including all inborn infants <27 weeks' gestation as well as older gestational age infants enrolled in clinical trials. The Bayley was administered by the same nurse practitioner for all infants.
Culture-positive EOS was defined as a positive blood culture obtained within the first three days of life. Culturepositive LOS was defined as a positive blood culture obtained beyond three days of life. NEC was defined as stage 2 or greater based on Bell's criteria (15) . PDA was Data analysis was performed using SAS software (Version 9.4, SAS Institute Inc., Cary, NC, USA). Descriptive statistics were used to detail the cohort of infants based on BPD status. Multivariate modelling characterised the relationship between BPD severity and cognition while adjusting for other predictors, including birthweight, sepsis, IVH and PVL. Generalised linear modelling was performed for predictors of cognitive score. Statistical significance was set at p-value <0.05.
RESULTS

Perinatal characteristics
Of the 166 infants who met both the inclusion and exclusion criteria, 151 (91%) completed their follow-up evaluation with the BSID-III. The median gestational age of the sample was 26.57 weeks (IQR 24.86-28.00). As expected, gestational age varied across the spectrum of BPD severity level with the youngest median gestation seen in the severe BPD classification and the oldest median gestation in the no/mild BPD classification (p < 0.0001) ( Table 2) . Similarly, birthweight varied by BPD severity with the smallest infants in the severe BPD classification and larger infants in the no/mild BPD classification (p < 0.0001). Maternal chorioamnionitis (p = 0.210) and antenatal steroid exposure (p = 0.333) were similar across BPD severity levels. A multivariate generalised linear model was designed and fit to adjust for other potential predictors of poor cognitive score. Candidate variables included: gestational age, birthweight, EOS and LOS, NEC, any IVH, grade III/IV IVH and PVL. The best fitting model included birthweight, early and LOS, any IVH, and PVL. In multivariate generalised model, BPD severity level was not a significant predictor of cognitive score (p = 0.503), while any IVH (p = 0.045) and PVL (p = 0.005) were significant predictors (Table 4) .
Secondary outcomes
Next, we analysed Bayley cognitive score as a dichotomous variable using two cut-points, cognitive score <85 and <70 (Table 3) . Thirty-six per cent of infants had cognitive scores <85. Univariate analysis found no significant difference in the odds of a cognitive score <85 based on BPD severity level (p = 0.456). Multivariate logistic regression did not reveal any difference in the odds of cognitive score <85 for infants with moderate BPD (aOR 1.36, 95% CI: 0.45-4.11, p = 0.891) or severe BPD (aOR 1.65, 95% CI 0.55-4.99, p = 0.415) compared to those with no/mild BPD. None of the covariates were significant predictors of Bayley cognitive score <85 in the multivariate analysis.
There were seven infants with cognitive scores <70, all of whom had severe BPD (7/83, 8%). Univariate analysis did not reveal a statistically significant association between cognitive score <70 and BPD severity category (p = 0.068). Logistic regression, including an adjusted analysis, could not be performed as there were no infants with cognitive scores <70 in the no/mild and moderate BPD categories.
Bayley language score did not differ significantly across BPD severity levels with a median score of 94 (IQR 89-100) for no/mild BPD, 94 (IQR 83-100) for moderate BPD and 89 (IQR 81-97) for severe BPD (p = 0.116). Bayley motor score also did not differ across BPD severity levels with a median score of 88 (IQR 85-91) for no/mild BPD, 88 (IQR 82-93) for moderate BPD and 85 (IQR 79-91) for severe BPD (p = 0.086). The incidence of other components of neurodevelopmental impairment, specifically, cerebral palsy (p = 1), hearing loss (p = 0.328) and blindness (p = 1) were similar across the BPD severity levels.
DISCUSSION
In the era of surfactant and gentler ventilation, BPD severity level did not predict worse cognition in a singlecentre cohort of VLBW infants. As anticipated, the infants with severe BPD had a younger median gestational age and lower birthweight than the infants with moderate or no/mild BPD. After adjusting for covariates, BPD severity level was not a significant predictor of the Bayley cognitive score. While all infants with cognitive score <70 had severe BPD (8% of infants with severe BPD), the majority of infants with severe BPD (60%) had cognitive scores >85. There was no difference in the odds of cognitive score <85 for the infants with no/mild BPD compared to the infants with severe BPD. The Bayley language and motor scores also did not differ significantly across BPD severity levels. Historically, BPD has been a morbidity of prematurity associated with a risk of poor neurodevelopmental outcomes (3) (4) (5) (6) 18, 19) . Schmidt et al. introduced predictive modelling of poor neurodevelopmental outcome at 18 months corrected age based on three neonatal morbidities: BPD, brain injury and severe ROP (20) . BPD had a 2.4-fold risk of poor neurological outcome, more than doubling the risk of poor outcome. In a sample of school-age survivors with BPD born 1975-1977, Vohr et al. reported more motor and academic difficulties compared to full-term infants (21) . In the era of classic BPD (cohort born in the 1980s), Majnemer et al. found that infants with BPD requiring home oxygen therapy were at greater risk of neurological and motor deficits at school age (22) . Others, consistent with our findings after adjusting for covariates, did not find BPD to be independently associated with neurological impairment after adjusting for IVH, ventricular dilation and sepsis (23) .
More recently, Trittmann et al. did not find an association between supplemental oxygen at discharge and neurodevelopmental impairment at 18 months of corrected age (24) . In contrast, Lodha et al. reported rates of disabilityfree survival at three years to be 79% in infants without BPD, higher than the 58-66% rate in infants with BPD (25) . However, the infants whose BPD required home oxygen did not have a higher incidence of neurodevelopmental disability at three years compared to infants with BPD who were discharged on room air. The Canadian Neonatal Network found that the use of oxygen and/or respiratory support, rather than use of oxygen alone, to define BPD had a better predictive value of respiratory and neurosensory morbidities at 18-21 months of age in the current era (26) .
Strengths of this analysis include the application of the NIH consensus definition of BPD to a contemporary cohort of preterm infants. Additionally, we adjusted our models of cognitive score and BPD by multiple covariates, including birthweight, EOS and LOS, any IVH and PVL. Our analysis contributes to a better understanding of the relationship between cognition and BPD in the era of surfactant and gentler or non-invasive ventilation.
The major limitation of this analysis is that it is a singlecentre retrospective design. The design limited the sample size because not all preterm infants were eligible for BSID-III evaluation. The follow-up rate differed across the spectrum of BPD severity, ranging from 22% for no/mild BPD to 62% for severe BPD. The population who received a follow-up evaluation including the BSID-III was enriched with smaller, sicker infants who were at higher risk for both poor neurodevelopmental outcomes and for severe BPD due to the criteria for administration of the BSID-III at our centre. The age range at BSID-III administration was relatively wide, 18-26 months of corrected age. The targeted window for follow-up changed from 18 to 22 months (if born prior to July 2012) to 22-26 months (if born in or after July 2012) during the study period.
Another limitation was the lack of data on parental education level and socioeconomic status, which impact early childhood cognitive outcomes. A primary caregiver with higher education attainment was associated with BSID-III composite scores ≥100 at 18-21 months of corrected age within the Canadian Neonatal Network (27) . Maternal education level has also been associated with reading and mathematics scores for school-age children (28) . There is a double jeopardy or negative synergistic effect for infants born prematurely and born into impoverished settings (29, 30) .
In this retrospective, single-centre study of a cohort of infants born 2009-2012, we found that modern BPD may not be predictive of cognitive, motor or language impairment at 18-22 months corrected age after adjustment for other predictive biological variables of poor developmental outcome. In our cohort, despite historical data suggesting that BPD is correlated with poor cognitive outcome, the majority of all infants with BPD, including those with severe BPD, had cognitive scores in the unimpaired range in toddlerhood. The next step in this area of investigation is to apply the classification schema of BPD from this analysis to a prospective, multi-centre sample and assess its predictive value of long-term neurological and pulmonary sequelae compared to historical definitions of BPD. This will better inform counselling of families regarding the long-term prognosis of preterm infants with lung disease related to prematurity.
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